METHODOLOGY FOR LOCAL SKIN EDEMA CALCULATING IN BREAST CANCER
https://doi.org/10.18027/2224-5057-2021-11-4-14-22
Abstract
Breast cancer with skin involvement is one of the least studied and at the same time difficult to treat forms of cancer. Despite the achievements of modern diagnostics, many issues related to skin edema severity evaluation and quantitative assessment of changes associated with neoadjuvant drug therapy often cause a number of difficulties. In turn, this can lead to both incorrect staging and «overtreatment» of patients, as well as subjectivity in assessing the response to the treatment. Various approaches have been proposed to calculate the severity of edema, but they have not been widely accepted. This article presents our method developed for determining the area of skin edema, which in the future will allow individualizing approaches to treatment.
About the Authors
V. A. Amosova
N. N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
Viktoriya A. Amosova, Postgraduate Student, Oncologist, Telemedicine Department
Moscow
A. K. Zagashtokova
N. N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
Albina K. Zagashtokova, Postgraduate Student
Moscow
M. S. Karpova
N. N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
Marina S. Karpova, MD, PhD, Radiologist, Radiodiagnosis Department
Moscow
N. V. Ponedelnikova
N. N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
Natalia V. Ponedelnikova, MD, PhD, Radiologist, Radiodiagnosis Department
Moscow
A. A. Kasimova
N. N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
Anastasia A. Kasimova, Radiologist, Radiodiagnosis Department
Moscow
O. P. Trofimova
N. N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
Oksana P. Trofimova, MD, PhD, DSc, Leading Researcher of the Department of Radiotherapy, Radiotherapist, N. N. Blokh‑ in National Medical Research Center of Oncology; Professor, Department of Oncology and Palliative Medicine named after A. I. Savitsky, Russian Medical Academy of Continuous Professional Education of the Ministry of Health of Russia
Moscow
M. A. Frolova
N. N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
Mona A. Frolova, MD, PhD, DSc, Leading Research Associate, Chemotherapy Department No. 1
Moscow
E. S. Makarov
N. N. Blokhin National Medical Research Center of Oncology
Russian Federation
Russian Federation
Evgeniy S. Makarov, MD, PhD, Senior Researcher, Department of Surgery No. 15 (Combined Treatment of Breast Tumors)
Moscow
A. V. Petrovsky
N. N. Blokhin National Medical Research Center of Oncology; I. M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Alexander V. Petrovsky, MD, PhD, Deputy Director for Education, Head of the Department of Combined Treatment of Breast Tumors, N. N. Blokhin National Medical Research Center of Oncology, Associate Professor, Department of Oncology, Institute of Clinical Medicine, I. M. Sechenov First Moscow State Medical University
Moscow
References
1. NCCN Guidelines Version 2.2021 Breast Cancer
2. Morrish HF. The significance and limitations of skin thickening as a diagnostic sign in mammography. Am J Roentgenol Radium Ther Nucl Med. 1966 Apr;96 (4):1041-5.
3. Loehberg CR, Lux MP, Ackermann S. Neoadjuvant chemotherapy in breast cancer; which diagnostic procedures can be used? Anticancer Res 2005;25:2519–26.
4. Yang W. T., Le-Petross H. T., Macapinlac H. et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res. Treat. 2008; 109: 417–426.
5. Günhan-Bilgen I., Ustun E. E., Memis A. Inflammatory breast carcinoma: mammographic, ultrasonographic, clinical, and pathologic findings in 142 cases. Radiology. 2002; 223: 829–838.
6. Kalli S, Freer PE, Rafferty EA. Lesions of the skin and superficial tissue at breast MR imaging. Radiographics 2010;30:1891-1913
7. Zucali R, Kenda R. Small Size-T4 Breast-Cancer. Natural History and Prognosis. Tumori. 1981;67 (3):225-30.
8. Güth, U., Singer, G., Schötzau, A., Langer, I., Dieterich, H., Rochlitz, C., … Wight, E. (2005). Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey. Annals of Oncology, 16 (10), 1618–1623.
9. Guth U, Singer G, Langer I, et al. T4 category revision enhances the accuracy and significance of stage III breast cancer. Cancer 2006;106:2569-2575.
10. Guth U, Wight E, Schotzau A, et al. A new approach in breast cancer with non-inflammatory skin involvement. Acta Oncol 2006;45:576-583
11. Guth U, Wight E, Singer G. Breast cancer with noninflammatory skin involvement: new data revise the traditional image of a «classical» clinicopathologic entity. Praxis (Bern 1994) 2006;95:1829-1835
12. Gueth U, Wight E, Schoetzau A, et al. Non-inflammatory skin involvement in breast cancer, histologically proven but without the clinical and histological T4 category features. J Surg Oncol 2007;95:291-297.
13. Wieland AW, Louwman MW, Voogd AC, van Beek MW, Vreugdenhil G, Roumen RM. Determinants of prognosis in breast cancer patients with tumor involvement of the skin (pT4b). Breast J 2004;10:123-128
14. Silverman D, Ruth K, Sigurdson ER, Egleston BL, Goldstein LJ, Wong YN, Boraas M, Bleicher RJ. Skin involvement and breast cancer: are T4b lesions of all sizes created equal? J Am Coll Surg. 2014 Sep;219 (3):534-44).
15. Mateo AM, Mazor AM, DeMora L, Sigurdson ER, Handorf EA, Daly JM, Aggon AA, Obeid E, Hayes SB, Bleicher RJ. Patterns of Care and Efficacy of Chemotherapy and Radiotherapy in Skin-Involved Breast Cancers of All Sizes. Clin Breast Cancer. 2019 Aug;19 (4):292-303.
16. Pope TL Jr, Read ME, Medsker T, Buschi AJ, Brenbridge AN. Breast skin thickness: normal range and causes of thickening shown on film-screen mammography. J Can Assoc Radiol. 1984 Dec;35 (4):365-8.
17. Ermakov A. V., Saribekyan E. K., Stepanov S. O., Rubtsova N. A., Kolesnikova E. V. The using of the instrumental methods of skin thickness measurement for the diagnosis of inflammatory breast cancer. Malignant Tumours 2015; 4: 24–27.
18. Колесник А. Ю., Шершнева М. А., Меских Е. В., Чхиквадзе В. Д., Нуднов Н. В. Новые подходы к диагностическому алгоритму отечноинфильтративной формы рака молочной железы (обзор литературы). Медицинская визуализация. – 2014. № 5 С. 124-129.
19. Бурдина Л. М. и др. Применение радиотермометрии для диагностики рака молочной железы. Маммология. 1998. № 2. С. 3–12
20. Cheung YC, Chen SC, Su MY, See LC, Hsueh S, Chang HK, Lin YC, Tsai CS. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Cancer Res Treat. 2003 Mar;78 (1):51-8.
21. Londero V, Bazzocchi M, Del Frate C, Puglisi F, Di Loreto C, Francescutti G, Zuiani C. Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy. Eur Radiol. 2004 Aug;14 (8):1371-9.
22. Manal Hamisa, Naglaa Dabess, Raghda Yosef, Fatma Zakeria, Qanet Hammed, Role of breast ultrasound, mammography, magnetic resonance imaging and diffusion weighted imaging in predicting pathologic response of breast cancer after neoadjuvant chemotherapy, The Egyptian Journal of Radiology and Nuclear Medicine, 46 (1) 2015, 245-257
23. Whitman GJ, Strom EA. Workup and staging of locally advanced breast cancer. Semin Radiat Oncol 2009;19 (4):211
24. Gonzalez AM. Breast cancer, neoadjuvant chemotherapy and residual disease. Clin Transl Oncol 2010;12 (7):461–7.
25. Rieber A, Brambs H, Gabelmann A. Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 2002;12:1711–9.
26. Martincich L , Montemurro F, De Rosa G. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004;83 (1):67–76.
27. Shoma A, Moutamed A, Ameen M. Short communication: ultrasound for accurate measurement of invasive breast cancer tumor size. Breast J 2006;12 (3):252–6.
28. Wright FC, Zubovits J, Gardner S. Optimal assessment of residual disease after neo-adjuvant therapy for locally advanced and inflammatory breast cancer-clinical examination, mammography, or magnetic resonance imaging? J Surg Oncol 2010;101 (7): 604–10
29. Chen M, Zhan WW, Han BS. Accuracy of physical examination, ultrasonography, and magnetic resonance imaging in predicting response to neo-adjuvant chemotherapy for breast cancer. Chin Med J 2012;125(11):1862–6.
Review
For citations:
Amosova V.A., Zagashtokova A.K., Karpova M.S., Ponedelnikova N.V., Kasimova A.A., Trofimova O.P., Frolova M.A., Makarov E.S., Petrovsky A.V. METHODOLOGY FOR LOCAL SKIN EDEMA CALCULATING IN BREAST CANCER. Malignant tumours. 2021;11(4):14-22. (In Russ.) https://doi.org/10.18027/2224-5057-2021-11-4-14-22
Views:
508
Email this article 